Khadidja Abdallah

Publication Activity (10 Years)

Years Active: 2022-2024
Publications (10 Years): 10

Top Topics

Sickle Cell Disease

Health Information

Top Venues

Orphanet journal of rare diseases

Clinical drug investigation

Science translational medicine

This page only lists publications with an associated author ORCID identifier.

Publications

Khadidja Abdallah, Isabelle Huys, Kathleen J Claes, Steven R A Simoens
Budget Impact of Disease-Modifying Treatments and a CRISPR Gene-Edited Therapy for Sickle Cell Disease. Clinical drug investigation (2024)
Khadidja Abdallah, Isabelle Huys, Kathleen J Claes, Steven R A Simoens
Budget Impact of Disease-Modifying Treatments and a CRISPR Gene-Edited Therapy for Sickle Cell Disease. Clinical drug investigation 44 (8) (2024)
Olabimpe Olayiwola, Adam Castillejo, Michael Louella, Moses Supercharger, Evelyn Harlow, Lynda Dee, Khadidja Abdallah, Cissy Kityo-Mutuluuza, Jennifer E Adair, Rimas J Orentas, Karine Dube
Nothing about us without us: Advocacy and engagement in genetic medicine. Science translational medicine 16 (746) (2024)
Khadidja Abdallah, Isabelle Huys, Kathleen J Claes, Steven R A Simoens
Budget Impact of Disease-Modifying Treatments and a CRISPR Gene-Edited Therapy for Sickle Cell Disease. Clinical drug investigation 44 (8) (2024)
Khadidja Abdallah, Kathleen Claes, Isabelle Huys, Lennert Follon, Charlotte Calis, Steven Simoens
Exploring alternative financing models and early access schemes for orphan drugs: a Belgian case study. Orphanet journal of rare diseases 17 (1) (2022)
Khadidja Abdallah, Kathleen Claes, Isabelle Huys, Lennert Follon, Charlotte Calis, Steven Simoens
Exploring alternative financing models and early access schemes for orphan drugs: a Belgian case study. Orphanet journal of rare diseases 17 (1) (2022)
Khadidja Abdallah, Kathleen Claes, Isabelle Huys, Lennert Follon, Charlotte Calis, Steven Simoens
Exploring alternative financing models and early access schemes for orphan drugs: a Belgian case study. Orphanet journal of rare diseases 17 (1) (2022)
Khadidja Abdallah, Kathleen Claes, Isabelle Huys, Lennert Follon, Charlotte Calis, Steven Simoens
Exploring alternative financing models and early access schemes for orphan drugs: a Belgian case study. Orphanet journal of rare diseases 17 (1) (2022)
Khadidja Abdallah, Kathleen Claes, Isabelle Huys, Lennert Follon, Charlotte Calis, Steven Simoens
Exploring alternative financing models and early access schemes for orphan drugs: a Belgian case study. Orphanet journal of rare diseases 17 (1) (2022)
Khadidja Abdallah, Kathleen Claes, Isabelle Huys, Lennert Follon, Charlotte Calis, Steven Simoens
Exploring alternative financing models and early access schemes for orphan drugs: a Belgian case study. Orphanet journal of rare diseases 17 (1) (2022)